Bromoacetamide-PEG3-C1-acid ide-acid InChi: InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4

InChi: InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4

Solubility: H2O : ≥ 200 mg/mL (634

Compared with the adhesion model group

1 nM in a BT20 cell assay

The Aβ deposition in brains of Methysticin-treated APP/Psen1 mice is not altered compared to untreated mice

Bromoacetamide-PEG3-C1-acid ide-acid InChi: InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4Bromoacetamide PEG3 C1 acid is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 173323 22 3 Molecular Weight: 328. 16 Formula: C10H18BrNO6 Chemical Name: 2 (2 {2 [2 (2 bromoacetamido)ethoxy]ethoxy}ethoxy)acetic acid Smiles: OC(=O)COCCOCCOCCNC(=O)CBr InChiKey: YTQSICXMSXKITM UHFFFAOYSA N InChi: InChI=1S C10H18BrNO6 c11 7 9(13)12 1 2 16 3 4 17 5 6 18 8 10(14)15 h1 8H2,(H,12,13)(H,14,15) Technical